← Open Payments lookup

MANORANJAN MUTHUKANAGARAJ: Open Payments

NPI 1750765244 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$502 in 25 payments from 10 companies in 2025. Trend: 2023 $619 · 2024 $883 · 2025 $502

Food & beverage: $502
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$112
Alkermes, Inc.3$75
Neurocrine BioSciences, Inc.4$74
Teva Pharmaceuticals USA, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.3$58
E.R. Squibb & Sons, L.L.C.2$39
ABBVIE INC.2$34
Janssen Pharmaceuticals, Inc1$22
Collegium Pharmaceutical, Inc.1$14
Vanda Pharmaceuticals Inc.1$14

Products named: ARISTADA, INGREZZA, TRINTELLIX, REXULTI, COBENFY, ABILIFY ASIMTUFII, VRAYLAR, UZEDY.

Industry payments across NC — which companies pay providers there.